Statins Reverse Doxorubicin Resistance in Mesothelioma Cells
Statins reverse doxorubicin resistance in human malignant mesothelioma cells in culture, a finding that may lead to new clinical strategies to improve doxorubicin efficacy in this hard to treat cancer.
This entry was posted on Thursday, July 13th, 2006 at 11:20 pm and is filed under Research, Mesothelioma. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.